Recombinant DCAF13 Antibody - Anticorpo primario, specific to DCAF13, Rabbit IgG

Cat. No.: Ab099227
Disponibile su ordine
QUALITÀ & PUREZZA Recombinant ? Recombinant — produced via recombinant expression for defined sequence and consistency. Use for reproducible, animal-free proteins of known origin. ExactAb™ ? ExactAb™ — Aladdin's antibody line emphasizing precision and validated quality. Use for reliable, specificity-validated antibody applications. Validated ? Validated grade — performance confirmed in defined applications before release. Use when you want documented assurance the reagent works as stated. See COA
Application
WB
Host species
Coniglio
Reactive species
consiglio, Mouse, Umano
Isotype
Rabbit IgG
Conjugation
Unconjugated
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
10μl
Ab099227-10μl
—
1 Disponibile
86,69€
50μl
Ab099227-50μl
—
1 Disponibile
225,53€
100μl
Ab099227-100μl
Su ordinazione · 8–12 settimane
364,36€
1ml
Ab099227-1ml
Su ordinazione · 8–12 settimane
2.950,23€
Enter a quantity for the sizes you want to add.

Panoramica

Rabbit anti Human DCAF13 Antibody, Recombinant, could be used for WB and so on.

Specifiche

Product Name
Recombinant DCAF13 Antibody - Anticorpo primario, specific to DCAF13, Rabbit IgG
Sinonimi
DCAF13 antibody|DDB1 and CUL4 associated factor 13 antibody|DDB1- and CUL4-associated factor 13 antibody|GM83 antibody|HSPC064 antibody|MGC126859 antibody|WD repeat and SOF domain-containing protein 1 antibody|WD repeats and SOF1 domain containing antibody|WDSOF1 antibody|DCAF13|GM83|Sof1|WDSOF1
Specifiche e purezza
Recombinant, ExactAb™, Validated, See COA
Meccanismi biochimici e fisiologici
Possible role in ribosomal RNA processing. May function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex.
Specie ospite
Coniglio
Specificità
DCAF13
Immunogeno
A synthetic peptide derived from human DCAF13 (AA 1-46).
Controllo positivo
WB: HeLa, Jurkat, Hep G2, MCF7, HEK293, NIH/3T3 and C6 cell lysates.
Coniugazione
Unconjugated
Grado
ExactAb™, Recombinant, Validated
Isotipo
Rabbit IgG
Tipo di catena leggera
kappa
Metodo di purificazione
Protein A purified
Concentrazione
See COA
Product Line
Prodotti biologici
Stoccaggio e spedizione
Forma
Liquid
Condizioni di conservazione di stoccaggio
Store at -20°C,Avoid repeated freezing and thawing
Spedito in
Ice chest + Ice pads
Stabilità e conservazione
Store at 4℃ short term (1-2 weeks). Store at -20℃ long term (24 months). Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
Immagini

Recombinant DCAF13 Antibody (Ab099227) - Western Blot
All lanes: Recombinant DCAF13 Antibody (Ab099227) at 1/1000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab176443) at 1/20000 dilution

Predicted band size: 51 kDa
Observed band size: 47 kDa
Exposure time: 37.6 s

Applicazione
Applicazione
Dilution info
WB

1/1000-1/2000

Dati avanzati

Obiettivi associati (umani)
DCAF13 Tbio DDB1- and CUL4-associated factor 13 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

2 results found

Lot NumberCertificate TypeDataOggetto
ZJ24F1012068ZJ24F1012068Certificate of AnalysisAug 10, 2026 Ab099227
ZJ24F1012069ZJ24F1012069Certificate of AnalysisAug 10, 2026 Ab099227
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Application Protocols

Manufacturer-validated applications, recommended dilutions, positive controls, and detailed protocols are not specified for this item; refer to the CoA/Spec Sheet.

General reminders (non-item-specific):

  • Match secondary antibody to the primary’s species and isotype.
  • Include appropriate positive/negative controls and perform titration to optimize signal-to-noise.

For authoritative instructions specific to Ab099227, consult the product’s CoA/validation documents.

Biological Roles

Target overview (literature/general):

  • DCAF13 (DDB1- and CUL4-associated factor 13), also known as WD repeat-containing protein 26 or other aliases depending on species annotation, functions as a substrate receptor within the CUL4-DDB1 E3 ubiquitin ligase complex (CRL4). As a DCAF, it helps recruit specific protein substrates to the scaffolded ubiquitin ligase for ubiquitination and subsequent proteasomal degradation or regulatory modification.
  • Structural features: DCAF proteins commonly contain WD40 repeat domains that form beta-propeller structures mediating protein–protein interactions. Exact domain architecture and post-translational modifications of DCAF13 depend on species and are documented in the literature.

Research relevance (general):

  • Studying DCAF13 can elucidate ubiquitin-mediated proteostasis, cell cycle control, DNA damage response coordination via DDB1/CUL4, and substrate selection mechanisms in CRL complexes.
  • An anti-DCAF13 antibody enables interrogation of endogenous expression levels, subcellular localization, and interaction networks through immunoassays (WB, IP/Co-IP, IF) when appropriately validated.

Caveats:

  • Expression patterns, isoforms, and functional partners may be cell- and tissue-specific. Always include genetic controls (siRNA/CRISPR) or orthogonal antibodies to strengthen conclusions.

Note: The above reflects general biology of the target protein; it is not item-specific performance data. For species reactivity and epitope details of this antibody, refer to the product CoA/Spec Sheet.

Buffer Applications

Not typically applicable. This product is an antibody reagent rather than a buffering agent. If buffer adjustments are required for your assay (e.g., conjugation, cell-based work), perform buffer exchange or dialysis into the appropriate system (PBS, HEPES, carbonate) as dictated by your protocol.

Green Alternatives

While “green alternatives” usually concerns solvent choices, sustainability considerations for antibodies focus on source, reproducibility, and hazard reduction.

Sustainability aspects (general):

  • Recombinant production: Compared with traditional animal-derived polyclonals, recombinant antibodies reduce animal use and enable consistent production in cell culture, aligning with 3Rs principles and reducing batch failures/waste.
  • Hazard minimization: Products formulated without sodium azide or other toxic preservatives lower hazardous waste burden. Presence/absence of azide for this item is not specified; refer to the label/CoA.
  • Concentrated formats: Higher stock concentrations can reduce packaging and cold-chain volume per experiment. Check CoA for actual concentration.

Comparison (general considerations):

  • Recombinant antibody vs hybridoma-derived: Higher lot-to-lot consistency and sequence-defined identity; typically improved reproducibility across studies.
  • Carrier-free formulations: Preferable for conjugation and cell-based assays, avoid proteinaceous carriers (e.g., BSA) that complicate downstream chemistry. Availability of a carrier-free version for this item is not specified.

Operational green tips:

  • Plan aliquots to minimize freeze–thaw and avoid discarding degraded material.
  • Use calibrated cold-chain logistics to prevent temperature excursions and reduce reshipments.
Pharmaceutical Uses

This product is supplied strictly for research use only (per Product Data). It is not intended for diagnostic, therapeutic, or in vivo use.

Formulation/CMC considerations for research workflows (general):

  • If using the antibody as a reference reagent in development labs, document excipients (e.g., glycerol, sugars, surfactants), pH, and ionic strength from the CoA.
  • For analytical method development (e.g., ligand-binding assays), confirm lot-to-lot consistency and establish bridging strategies if lots change.

No pharmacopeial status, excipient role, or GMP suitability is specified for this item.

Physical Properties

Item-specific properties:

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Concentration, formulation buffer, and excipients (e.g., glycerol, BSA, azide): Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight (kDa) and isotype: Not specified for this item; refer to CoA/Spec Sheet.

Notes on applicability to antibodies (literature/general):

  • Classical physicochemical constants such as boiling point, melting point, logP, and refractive index are not typically defined for macromolecular protein solutions and are not meaningful specifications for antibodies.
  • Solubility: Antibodies are generally water-soluble in physiological buffers (e.g., PBS, HEPES) with solubility and stability influenced by pH, ionic strength, and excipients. Aggregation propensity is formulation-dependent.
  • pI/pKa: Antibody isoelectric points vary widely (commonly pI ~6–9 for IgG; literature). The exact pI for this recombinant antibody is not specified for this item.
  • Viscosity and thermal stability: Both are highly formulation- and concentration-dependent; specific values are not specified for this item.

Conclusion: For exact concentration, buffer composition, additives, and any biophysical characterization (e.g., SDS-PAGE profile, monomer purity by SEC), consult the item’s CoA/Spec Sheet.

Quality and Grades

Item-specific quality notes (from Product Data):

  • Grade/Purity: Recombinant, ExactAb™, Validated.

Interpretation and implications (general guidance aligned to the listing; not a substitute for CoA):

  • Recombinant antibody: Produced from defined DNA sequences in a controlled expression system, enabling lot-to-lot genetic identity and scalability. Recombinant production reduces variability compared with hybridoma-derived monoclonals or polyclonals.
  • ExactAb™: Branded designation indicating a standardized recombinant format for enhanced batch consistency and sequence-defined identity. Specific performance metrics and sequence information are not specified for this item; refer to CoA/Spec Sheet.
  • Validated: Indicates the manufacturer has performed internal verification of target recognition and/or application performance. Exact validated applications, species reactivity, and data quality criteria are not specified here; consult the product CoA/validation data.

What to check on receipt (best practices):

  • Verify lot-specific CoA for concentration (mg/mL), isotype, light chain type, purity by SDS-PAGE/SEC, residual host-cell proteins/DNA, endotoxin (if applicable), and buffer/excipients.
  • Review validation images and protocols for your intended application (WB, IHC, IF, IP, ELISA), if provided.
  • Confirm absence/presence of sodium azide, BSA, glycerol, and carrier proteins if these affect downstream assays or conjugations.

Documentation: For regulatory or QA needs, retain CoA, SDS, and any sequence confirmation documents (if available for recombinant products).

Reaction and Applications

For antibodies, “applications” refers to immunoassays and affinity-based methods rather than chemical reactions.

General research applications for an anti-DCAF13 recombinant antibody (literature/general; not specific validations for this item):

  • Western blotting (WB): Detection of DCAF13 in denatured lysates; epitope accessibility depends on denaturation and transfer conditions. Use chemiluminescent or fluorescent secondaries matched to the isotype.
  • Immunoprecipitation (IP/Co-IP): Enrichment of DCAF13 and associated CRL4 complex members for downstream MS or WB analysis; consider gentle lysis buffers to preserve interactions.
  • Immunofluorescence/Immunocytochemistry (IF/ICC): Cellular localization studies for DCAF13; fixation/permeabilization conditions (PFA vs methanol) affect epitope presentation.
  • ELISA: Quantitative binding assays if the antibody is compatible with plate-based formats.
  • Knockdown/overexpression validation: Antibody signal modulation in samples with siRNA/CRISPR or exogenous DCAF13 constructs supports specificity.

Practical tips (general):

  • Optimize antibody dilution empirically; antigen abundance and lysis/fixation conditions strongly influence signal-to-noise.
  • Include positive controls (cells/tissues known to express DCAF13) and negative controls (isotype control, knockout/knockdown lysates).

Note: This item’s manufacturer-validated applications are not specified; consult the CoA/validation data before committing to critical experiments.

Reaction Conditions

Not applicable to chemical reaction conditions. For experimental conditions in immunoassays, refer to your specific protocol and the product’s CoA/validation data if provided. Typical parameters (antibody dilution, incubation time/temperature, blocking agents) are application-specific and are not specified for this item.

Safety and Handling

Item-specific safety information (from Product Data):

  • GHS classification, signal word, pictograms, and H-statements: Not specified for this item; refer to SDS.
  • Storage conditions: Store at -20°C. Avoid repeated freezing and thawing.
  • Shipping: Ice chest + ice pads.

General safety guidance for antibodies (literature/general; defer to SDS for authoritative guidance):

  • Antibodies are protein biologics typically supplied in aqueous buffers that may contain preservatives such as sodium azide (if present, it must be listed on the label/CoA). If azide is present, avoid contact with acids and copper/lead plumbing to prevent formation of explosive metal azides; dispose of azide-containing waste appropriately.
  • Personal protective equipment: lab coat, gloves, and eye protection when handling liquids and opening vials. Avoid aerosol generation and contact with skin or eyes.
  • First aid (general): Rinse skin/eyes with water in case of contact. If inhaled as an aerosol, move to fresh air. If ingested, rinse mouth and seek medical attention as needed. Always follow institutional biosafety procedures.
  • Incompatibilities and stability: Repeated freeze–thaw cycles can denature proteins and promote aggregation; aliquot upon first thaw to minimize freeze–thaw. Avoid microbial contamination; use sterile technique if product is preservative-free.
  • Spill/cleanup: Absorb with inert material, clean surfaces with suitable disinfectant if biological contamination risk is a concern.

Always consult the product label and SDS for lot-specific hazards and handling instructions.

Solvent Selection

This section is not typically applicable to antibodies, which are supplied in aqueous buffers rather than organic solvents.

Practical considerations (general):

  • Working buffer: Antibody stability is usually optimized in PBS or similar isotonic buffers at pH ~7–7.4. Exact formulation for this item is not specified; refer to the CoA/label.
  • Additives: Glycerol (e.g., 10–50%) is often included for freeze–thaw protection at −20°C; carrier proteins (e.g., BSA) may be present to reduce adsorption. Presence/absence is not specified for this item.
  • If buffer exchange is required (e.g., for conjugation), use spin desalting columns or dialysis into the desired buffer (HEPES, PBS, carbonate) while maintaining neutral pH and low ionic strength appropriate for the downstream chemistry.
Storage and Reconstitution

Item-specific instructions (from Product Data):

  • Storage: Store at -20°C. Avoid repeated freezing and thawing.
  • Shipping: Ice chest + ice pads.

Additional handling guidance (general):

  • Upon first thaw, aliquot into single-use volumes to minimize freeze–thaw cycles. If glycerol is present (check CoA/label), storage at −20°C without freezing (i.e., in 40–50% glycerol) can reduce freeze–thaw stress.
  • Protect from microbial contamination; use sterile tips and tubes. If the product is preservative-free, keep on ice during use and return promptly to −20°C.
  • If lyophilized/requires reconstitution: Reconstitution medium, target concentration, and buffer are not specified for this item; refer to the CoA/Spec Sheet before adding any solvent or buffer.
  • Do not expose to repeated temperature cycling; record date of first opening and track aliquot usage.

Always follow lot-specific instructions provided on the label and CoA.

Structure and Identity

Item-specific identifiers (from Product Data):

  • Product name: Recombinant DCAF13 Antibody (SKU: Ab099227)
  • Grade/Purity: Recombinant, ExactAb™, Validated
  • Category: Antibody (research use only)
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES / InChI / InChIKey: Not applicable to protein biologics; not specified for this item.

General structural description (literature/general):

  • This product is described as a recombinant antibody, i.e., an engineered immunoglobulin produced in a defined expression system. Typical IgG architecture comprises two heavy chains and two light chains forming a Y-shaped heterotetramer with variable domains (VH/VL) conferring antigen binding and constant domains (CH/CL) determining isotype and effector functions.
  • The antigen target indicated by the product name is DCAF13 (DDB1- and CUL4-associated factor 13), implying antigen-binding site specificity toward epitopes within DCAF13. Epitope location, isotype, clone ID, and host species are not specified for this item; refer to CoA/Spec Sheet.
  • Post-translational features such as glycosylation and disulfide bonds are typical for IgG-class antibodies; exact glycoform content is product- and batch-dependent and not specified here.
Synthetic Utility

Not applicable. Antibodies are biologic affinity reagents and are not used as synthetic building blocks or reagents in chemical synthesis. For relevant information, see Reaction & Applications and Application Protocols for immunoassay use.

Target Specificity

Item-specific details (from Product Data):

  • Antigen/Target: DCAF13 (implied by product name: Recombinant DCAF13 Antibody)
  • Clone ID, isotype, host species, and species reactivity: Not specified for this item; refer to CoA/Spec Sheet.
  • Epitope and affinity/avidity metrics: Not specified for this item; refer to CoA/Spec Sheet.

General note: Confirm specificity with appropriate controls (genetic knockdown/knockout, overexpression, or orthogonal antibodies) in your experimental system.

Domande frequenti

What does ExactAb? mean?
ExactAb? indicates the product has been validated for use in rigorous antibody validation workflows. Validation may include positive/negative control samples, signal-to-noise testing, and protocol-specific QC. Lot-specific test data is published on the Certificate of Analysis where available.
What does Recombinant mean?
Recombinant is a defined analytical purity tier suitable for workflows requiring a specific validated property. It specifies a minimum assay percentage, controlled limits on common impurities (water, heavy metals, residue on ignition), and lot-to-lot consistency. Recombinant is one of several purity tiers — choose based on the sensitivity and regulatory requirements of your method.
How should this product be stored?
Store at ?20 °C. Avoid repeated freeze–thaw cycles. Aliquot into single-use volumes before freezing.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
Which species reactivity has this antibody been validated against?
Validated reactivity is listed on the PDP and on each lot's datasheet. We validate against the most commonly tested species for the target (Recombinant DCAF13 Antibody); cross-reactivity in untested species may exist but is not guaranteed. Contact technical support for specific species inquiries.

Hai bisogno di aiuto per scegliere la qualità?

La nostra guida alla selezione delle qualità copre purezza, stato dello stabilizzatore e idoneità all'applicazione per tutte le varianti del nostro catalogo.

Visualizza la guida alle qualità Recombinant → Visualizza la guida alle qualità Validated → Visualizza la guida alle qualità ExactAb™ →

Prodotti correlati

Goat Anti-Rabbit IgG H&L Antibody - Anticorpo secondario, for ELISA,LF,GICA various applications, from Rabbit, generated in Goat
Goat Anti-Rabbit IgG H&L (AF594) - Anticorpo secondario, IgG
Goat Anti-Rabbit IgG H&L (Biotin) - Anticorpo secondario, IgG
Goat Anti-Rabbit IgG H&L (AF488) - Anticorpo secondario, IgG
Goat Anti-Rabbit IgG H&L (AF405) - Anticorpo secondario, IgG
Donkey Anti-Rabbit IgG H&L (AF647) - Anticorpo secondario, specific to , IgG
Donkey Anti-Rabbit IgG H&L (Biotin) - Anticorpo secondario, IgG
Goat Anti-Rabbit IgG H&L (HRP) - Anticorpo secondario
Goat Anti-Rabbit IgG H&L Antibody - Anticorpo secondario, Goat IgG
Goat Anti-Rabbit IgG H&L (Biotin) - Anticorpo secondario
Goat Anti-Rabbit IgG H&L (Cy5) - Anticorpo secondario
Goat Anti-Rabbit IgG H&L (FITC) - Anticorpo secondario
Goat Anti-Rabbit IgG H&L (TRITC) - Anticorpo secondario
Goat Anti-Rabbit IgG H&L (Biotin) - Anticorpo secondario, Goat IgG
Goat Anti-Rabbit IgG H&L (HRP) - Anticorpo secondario, Goat IgG
Goat Anti-Rabbit IgG H&L (Cy5) - Anticorpo secondario, Goat IgG
Goat Anti-Rabbit IgG H&L (TRITC) - Anticorpo secondario, Goat IgG
Goat Anti-Rabbit IgG H&L (FITC) - Anticorpo secondario, Goat IgG
Goat Anti-Rabbit IgG H&L (PE) - Anticorpo secondario, Goat IgG
Goat Anti-Rabbit IgG H&L (APC) - Anticorpo secondario, Goat IgG
Goat Anti-Rabbit IgG H&L (AF647) - Anticorpo secondario, Goat IgG
Goat Anti-Rabbit IgG H&L (AF405) - Anticorpo secondario, Goat IgG
Goat Anti-Rabbit IgG H&L (AF555) - Anticorpo secondario, Goat IgG
Goat Anti-Rabbit IgG H&L (AF546) - Anticorpo secondario, specific to Rabbit IgG
Goat Anti-Rabbit IgG H&L (AF700) - Anticorpo secondario, specific to Rabbit IgG
Goat Anti-Rabbit IgG H&L (AF488) - Anticorpo secondario
Goat Anti-Rabbit IgG H&L (AF647) (Ready to use) - Anticorpo secondario, specific to Rabbit IgG

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.